Navigation Links
Leading Immunologists Convene in Boston
Date:6/2/2008

Annual meeting of the Federation of Clinical Immunology Societies opens June 5

BOSTON, June 2 /PRNewswire-USNewswire/ -- Over a thousand scientists and clinicians will convene to present new advances in understanding and treating immune-mediated diseases at FOCIS 2008, the 8th annual meeting of the Federation of Clinical Immunology Societies (FOCIS), June 5-9 at the Boston Marriott Copley Place.

Conference participants will present new research findings for conditions in which the human immune system plays a significant role, such as Multiple Sclerosis, cancer, allergy and asthma, diabetes, inflammatory bowel disease, and AIDS. The topics and speakers will address underlying immune pathogenesis, novel therapies and shared insights on topics such as new mechanisms and therapeutic targets, innovations in genetic approaches and how inflammatory regulators communicate danger.

In contrast to traditional medical meetings which focus on particular medical specialties, the FOCIS approach is to highlight and probe the underlying common elements of diseases which can lead to better therapies. "As the immunology field rapidly advances in clinical trials and the introduction of new and specific immunotherapies the opportunity to share knowledge and speed progress has never been greater," says Dr. Jerry Nepom, MD, PhD, Director of the Benaroya Research Institute at Virginia Mason, Seattle, Wash. and president of FOCIS.

"Today, immunology represents a critical pathway to unlock answers to treat many of today's diseases. To that end, it is important to broaden the access to educational programs to further immunological knowledge for investigators, basic scientists and clinicians. The FOCIS annual meeting provides a forum for this timely exchange. This meeting brings special value by translating knowledge from basic science into multiple clinical disciplines to both understand and treat immune-based diseases," Nepom said.

Nepom says the translational approach to medicine is taking hold at medical schools and hospitals around the country. For instance, the National Institutes of Health, the US government's medical research body, launched its Roadmap for Medical Research to establish a call for scientists to move beyond the confines of their own discipline and explore new organizational models for team science.

"Translational medicine is the future, as we know it," Nepom said. "FOCIS has been the voice of translational immunology and we're very excited that this idea beginning to change the way we view medicine."

For more information about FOCIS 2008 and program scheduling, visit HYPERLINK "http://www.focisnet.org/" http://www.focisnet.org.


'/>"/>
SOURCE Federation of Clinical Immunology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
2. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
3. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
4. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
5. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
6. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
9. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
10. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
11. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):